Blood test could sniff out fatal fungus before It's too late

NCT ID NCT05406037

Recruiting now Diagnosis Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

Mucormycosis is a serious fungal infection with a high death rate, and early treatment is critical. This study is testing a new blood test that looks for a unique sugar marker from the fungus. Researchers will compare results from 100 people—those with the infection, those at high risk, and those with other fungal infections—to see if the test can accurately diagnose mucormycosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a faster, more accurate diagnostic test for mucormycosis, helping doctors start treatment sooner and potentially saving lives.
What could go wrong: This is an early-stage study with only 100 participants, so the test may not prove accurate enough or may not work in all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUCORALES INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Invasive Fungal Infections Zygomycosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MUCORALES INFECTION MUCORMYCOSIS

Contacts and locations

Locations

University Hospital of Lille
RECRUITING

Lille, Hauts-de-France, 59000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.